Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SENP6 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | HIST1H4H | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | FBXW7 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | DYRK1B | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PDP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | KBTBD6 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RIF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | IQCB1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |